North America Startup Funding Rounds
Startups raising capital across North America. Compare the businesses, funding stages and investors active in the region.
- Rounds
- 2,693 All time
- Disclosed funding
- $639.4B 2222 disclosed amounts
- Median round
- $25M Of disclosed amounts
| Company | Amount | Round | Sector | Country | Investors | Announced |
|---|---|---|---|---|---|---|
| IM Inquis MedicalCompany profile Develops mechanical thrombectomy systems for venous thromboembolic disease Develops mechanical thrombectomy systems for venous thromboembolic disease | $75M | Series CSeries C+ | Healthtech | United States | Investors Undisclosed | |
| M Provides software-based security for payments, identity, and digital assets | $10M | Undisclosed | Fintech | United States | Investors | |
| T TorqCompany profile Empowers enterprises to instantly and precisely detect and respond to security events at scale Empowers enterprises to instantly and precisely detect and respond to security events at scale | $140M | Series DSeries C+ | Cybersecurity | United States | Investors | |
| KT Develops inhaled therapies for severe respiratory diseases | $103M | Series B | Biotech | United States | Investors | |
| VS Develops a ureteroscopic system for complete kidney stone clearance | $30M | Series A | Healthtech | United States | Investors | |
| R Provides enterprise-grade infrastructure for stablecoin-powered payments | $250M | Series CSeries C+ | Fintech | United States | Investors | |
| MM Major Medical DevicesCompany profile Develops innovative vascular intervention solutions for abdominal aortic aneurysms Develops innovative vascular intervention solutions for abdominal aortic aneurysms | Undisclosed | StrategicUndisclosed | Healthtech | United States | Investors | |
| B BradoCompany profile Provides Conversational Engagement Platform for patient navigation and engagement Provides Conversational Engagement Platform for patient navigation and engagement | Undisclosed | Undisclosed | Healthtech | United States | Investors | |
MEDIPOSTCompany profile MEDIPOST develops stem-cell therapies derived from donated umbilical cord blood. MEDIPOST develops stem-cell therapies derived from donated umbilical cord blood. | $140M | Undisclosed | Biotech | United States | Investors | |
| CI Provides AI-native, full-stack insurance for startups | $108M | Series A | Fintech | United States | Investors |